Category Archives: AAI

Pathology laboratory in Rwanda expands diagnostic capacity to receive accreditation

Deaths due to cancer in Rwanda have doubled since 1990. With 50-fold fewer pathologists per capita than the USA, Rwanda lacks a pathology workforce needed to produce consistent and timely diagnoses for cancer patients. Given that late or inaccurate cancer diagnoses are a reliable predictor of adverse outcomes, strengthening diagnostic capacity will be crucial toContinue reading “Pathology laboratory in Rwanda expands diagnostic capacity to receive accreditation”

Customized training programs lead to knowledge exchanges between US and African pathologists

Without intervention, experts predict that cancer mortality in sub-Saharan Africa will double to 1 million deaths per year by 2040. Accurate diagnoses by pathology professionals are essential to positive cancer treatment outcomes, yet most African countries – including Nigeria – face a shortage of routine training opportunities that are needed to hone the oncology skills ofContinue reading “Customized training programs lead to knowledge exchanges between US and African pathologists”

Hands-on training equips Ivoirian clinicians with the tools for fast, accurate cancer diagnosis 

In late 2019, the University Hospital Center (CHU) Treichville in Abidjan, Côte d’Ivoire began exploring the treatment of aggressive forms of breast cancer with immunotherapy. Immunotherapies are a type of targeted cancer treatment that, unlike chemotherapy and radiation, avoid harming healthy cells. Despite their enthusiasm, the CHU Treichville team was unable to proceed due toContinue reading “Hands-on training equips Ivoirian clinicians with the tools for fast, accurate cancer diagnosis “

Drug access program provides affordable medicines to Cameroon’s cancer patients

The successful treatment of most cancers relies on the use of a cocktail of drugs that are administered at precise intervals over discrete periods of time. For example, one treatment regimen for Burkitt’s lymphoma (BL) – a cancer commonly found in Africa – requires administration of seven different drugs over a period of 15 days.Continue reading “Drug access program provides affordable medicines to Cameroon’s cancer patients”

We’ve reached an important milestone in addressing cancer in the U.S. – but success should not end there

By Jennifer Dent | President & CEO, BVGH According to a recent report issued by the American Cancer Society, cancer deaths in the United States have dropped 27 percent since 1991. This is an important milestone attributable, in large part, to lower smoking rates, advances in early detection of cancers, and the development of innovative treatments. WhileContinue reading “We’ve reached an important milestone in addressing cancer in the U.S. – but success should not end there”